Prevalence and Incidence of HCV Infection among Vietnam Heroin Users with Recent Onset of Injection

被引:0
|
作者
Michael C. Clatts
Vivian Colón-López
Le M. Giang
Lloyd A. Goldsamt
机构
[1] University of Puerto Rico,School of Public Health
[2] Hanoi Medical University,Center for Research and Training on HIV/AIDS
[3] National Development and Research Institutes,Center for Research on Global Health, Graduate School of Public Health
[4] Inc.,undefined
[5] University of Puerto Rico,undefined
[6] Medical Sciences Campus,undefined
来源
Journal of Urban Health | 2010年 / 87卷
关键词
Hepatitis C prevalence; HCV incidence; Onset and initiation of heroin injection; IDU's; Harm reduction; Vietnam;
D O I
暂无
中图分类号
学科分类号
摘要
HCV infection continues to spread at an alarming rate among IDU populations. The available evidence suggests that HCV is acquired relatively quickly following onset of injection. However, there are few prospective studies of HCV acquisition, particularly among IDU populations in resource-poor settings. A sample of young male heroin injectors with recent onset of injection (<4 years) was recruited in Hanoi, Vietnam for a prospective assessment of the early course of injection (n = 179). Both behavioral and biological assessments (including detailed retrospective assessment of injection initiation) were conducted at baseline and repeated at 6-month intervals for a period of 16 months. Variables associated with HCV infection (p value < 0.05) in bivariate analyses were considered for inclusion in logistic regression models to identify risk factors independently associated with HCV infection. HCV incidence was calculated by using the incidence density approach and was expressed in terms of person-years of observation. The baseline of prevalence of HCV was 46%. HCV significantly increased in relation to time since first injection, from 30% in subjects with ≤10 months of injection risk to 70% in subjects with ≥30 months injection risk (p value = 0.0005). In multivariate logistic regression analysis, increasing age, incarceration in a drug detention facility (OR = 2.54; 95%CI 1.05, 6.15), and time since first injection remained significantly associated with HCV infection. Use of injection as primary mode of administration (OR = 2.56; 95%CI 0.98, 6.69) achieved marginal significance. After 16 months of follow-up, the incidence rate of HCV was 23.35 per 100 person-years and the mean time between first injection and first positive HCV test was 1.2 years. HCV is acquired much more rapidly among new injector populations than previously recognized, demonstrating the need for early behavioral intervention among new heroin-user populations. Particularly critical are interventions that target new heroin user populations, including interventions that improve understanding of viral transmission dynamics, that promote alternative strategies for drug sharing, and that delay initiation of injection.
引用
收藏
页码:278 / 291
页数:13
相关论文
共 50 条
  • [21] PREVALENCE OF HCV INFECTION AMONG ALCOHOLICS
    SOLDEVILAPICO, C
    CHAPARALA, R
    GALLANT, D
    PENA, I
    LOK, ASF
    HEPATOLOGY, 1995, 22 (04) : 972 - 972
  • [22] Can HCV be prevented among injection drug users?
    Newmeyer, J
    JOURNAL OF PSYCHOACTIVE DRUGS, 2002, 34 (04) : 421 - 425
  • [23] The prevalence and incidence of HIV among injection drug users: A five year panel study
    Dale D. Chitwood
    Clyde B. McCoy
    Mary Comerford
    Kathi Kitner
    Population Research and Policy Review, 1999, 18 : 39 - 53
  • [24] Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users
    Latka, M
    Ahern, J
    Garfein, RS
    Ouellet, L
    Kerndt, P
    Morse, P
    Farshy, CE
    Des Jarlais, DC
    Vlahov, D
    JOURNAL OF SUBSTANCE ABUSE, 2001, 13 (1-2) : 73 - 88
  • [25] HIV PREVALENCE AND INCIDENCE AMONG INJECTION-DRUG USERS IN LOS-ANGELES
    LONGSHORE, D
    ANGLIN, MD
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1994, 7 (07): : 738 - 739
  • [26] The prevalence and incidence of HIV among injection drug users: A five year panel study
    Chitwood, DD
    McCoy, CB
    Comerford, M
    Kitner, K
    POPULATION RESEARCH AND POLICY REVIEW, 1999, 18 (1-2) : 39 - 53
  • [27] HCV seroconversion among never-injecting heroin users at baseline: No predictors identified other than starting injection
    Bravo, Maria J.
    Vallejo, Fernando
    Barrio, Gregorio
    Teresa Brugal, M.
    Molist, Gemma
    Pulido, Jose
    Sordo, Luis
    de la Fuente, Luis
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2012, 23 (05) : 415 - 419
  • [28] Prevalence of and risk factors for hepatitis B virus infection among street-recruited young injection and non-injection heroin users in Barcelona, Madrid and Seville
    Vallejo, Fernando
    Toro, Carlos
    de la Fuente, Luis
    Brugal, M. Teresa
    Soriano, Vicente
    Silva, Teresa C.
    Bravo, Maria Jose
    Ballesta, Rosario
    Barrio, Gregorio
    EUROPEAN ADDICTION RESEARCH, 2008, 14 (03) : 116 - 124
  • [29] A SIMPLE STRATEGY TO SCREEN FOR ACUTE HCV INFECTION AMONG NEWLY INCARCERATED INJECTION DRUG USERS
    Kim, Arthur Y.
    Birch, Christopher E.
    Nagami, Ellen H.
    Bowen, Melinda J.
    Lauer, Georg M.
    McGovern, Barbara H.
    HEPATOLOGY, 2009, 50 (04) : 668A - 668A
  • [30] HIV incidence among injection drug users
    Longshore, D
    Anglin, MD
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 11 (03): : 308 - 309